LORD, ABBETT & CO. LLC
Holdings History for GeneDx Holdings Corp. - Class A common stock, par value $0.0001 per share (WGS)
- Symbol
- WGS on Nasdaq
- Investment type
- Equity / Class A common stock, par value $0.0001 per share
Shares, Excluding Options vs Price
Value, Excluding Options
13F rows show quarter-end holdings reported by the manager. Values are filing-reported market values; price checks are local estimates.
| Holdings as of | Option type | Portfolio weight | Value change | SEC-reported value | Shares | Share change | Share activity | Price | All holders |
|---|---|---|---|---|---|---|---|---|---|
| 30 Jun 2026 | -0.01% | $0 | 0 | -42,648 | -100% | $62.60 | Q2 2026 | ||
| 31 Mar 2026 | 0.01% | -0.1% | $2,739,000 | 42,648 | -475,656 | -92% | $64.22 | Q1 2026 | |
| 31 Dec 2025 | 0.21% | -0% | $67,411,000 | 518,304 | -7,073 | -1.3% | $130.06 | Q4 2025 | |
| 30 Sep 2025 | 0.17% | +0.03% | $56,604,000 | 525,377 | +90,905 | +21% | $107.74 | Q3 2025 | |
| 30 Jun 2025 | 0.13% | +0.01% | $40,106,000 | 434,472 | +25,136 | +6.1% | $92.31 | Q2 2025 | |
| 31 Mar 2025 | 0.13% | -0.07% | $36,253,000 | 409,336 | -221,137 | $88.57 | Q1 2025 | ||
| 31 Dec 2024 | 0.15% | +0.15% | $48,458,000 | 630,473 | +630,473 | NEW | $76.86 | Q4 2024 |
SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held.
* marks a reported price that did not pass the local price check.
* marks a reported price that did not pass the local price check.